James Scott McClellan

Treatment advances have not improved the early death rate in acute promyelocytic leukemia

James Scott McClellan, Holbrook E. Kohrt, Steven Coutré et al. · Haematologica · 2011 · 165 citations · Full text

Medicine, Hematology, Oncology +13

Establishment and Maintenance of Gammaherpesvirus Latency Are Independent of Infective Dose and Route of Infection

Scott A. Tibbetts, Joy Loh, Victor van Berkel et al. · Journal of Virology · 2003 · 125 citations · Full text

Life Sciences, Infectious Diseases, Immunology Of Infectious Diseases +12

Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages

James Scott McClellan, Christopher G. Dove, Andrew J. Gentles et al. · Proceedings of the National Academy of Sciences · 2015 · 67 citations · Full text

Life Sciences, Cell Biology, Oncology +12

Effective Vaccination against Long-Term Gammaherpesvirus Latency

Scott A. Tibbetts, James Scott McClellan, Shivaprakash Gangappa et al. · Journal of Virology · 2003 · 67 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma

A. Keith Stewart, Amrita Krishnan, Seema Singhal et al. · Blood Cancer Journal · 2019 · 59 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17